Phenotypic Spectrum of the Foveal Configuration and Foveal Avascular Zone in Patients With Alport Syndrome.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
07 02 2020
Historique:
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 14 4 2020
Statut: ppublish

Résumé

To investigate characteristics of the foveal pit and the foveal avascular zone (FAZ) in patients with Alport syndrome (AS), a rare monogenetic disease due to mutations in genes encoding for collagen type IV. Twenty-eight eyes of nine patients with AS, and five autosomal-recessive carriers and 15 eyes from 15 age-similar healthy control subjects were examined using optical coherence tomography (OCT) and OCT-angiography (OCT-A). Foveal configuration and FAZ measures including the FAZ area, circularity, and vessel density in the central 1° and 3° were correlated. Foveal hypoplasia was found in 10 eyes from seven patients with either genotype. In contrast, a staircase foveopathy was found in seven eyes of four X-linked AS patients. The average FAZ area did not differ significantly between AS patients and control subjects (mean ± SD 0.24 ± 0.24 mm2 vs. 0.21 ± 0.09 mm2; P = 0.64). Five eyes showed absence or severe anomalies of the FAZ with crossing macular capillaries that was linked to the degree of foveal hypoplasia on OCT images leading to a significant inverse correlation of FAZ area and foveal thickness (r = -0.88; P < 0.001). In contrary, female patients with X-linked mutations exhibited a significantly greater FAZ area (0.48 ± 0.30 mm2 vs. 0.21 ± 0.09 mm2; P = 0.007), in line with OCT findings of a staircase foveopathy. The foveal phenotypic spectrum in AS ranges from foveal hypoplasia and absence of a FAZ to staircase foveopathy with an enlarged FAZ. Because the development of the FAZ and foveal pit are closely related, these findings suggest an important role for collagen type IV in foveal development and maturation.

Identifiants

pubmed: 32031577
pii: 2760834
doi: 10.1167/iovs.61.2.5
pmc: PMC7324255
doi:

Substances chimiques

Collagen Type IV 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5

Références

Ophthalmology. 2011 Aug;118(8):1653-60
pubmed: 21529956
J Clin Med. 2019 Feb 03;8(2):
pubmed: 30717457
Eur J Hum Genet. 2015 Sep;23(9):
pubmed: 25388007
Nat Rev Nephrol. 2013 Mar;9(3):170-8
pubmed: 23165304
Ophthalmology. 2017 Jun;124(6):896-902
pubmed: 28283280
J Am Soc Nephrol. 2013 Feb;24(3):364-75
pubmed: 23349312
Vision Res. 1986;26(6):847-55
pubmed: 3750868
Ophthalmic Genet. 2017 May-Jun;38(3):238-244
pubmed: 27485810
Ophthalmic Surg Lasers Imaging Retina. 2018 Feb 1;49(2):138-141
pubmed: 29443365
Retina. 2019 Dec;39(12):2332-2340
pubmed: 30204731
Br J Ophthalmol. 2012 Jul;96(7):961-6
pubmed: 22544530
J Am Soc Nephrol. 2013 Dec;24(12):1945-54
pubmed: 24052634
Ophthalmology. 1999 Jul;106(7):1409-13
pubmed: 10406630
Kidney Int. 2000 Sep;58(3):925-43
pubmed: 10972657
Mol Vis. 2009;15:45-59
pubmed: 19145251
Cell Rep. 2016 Oct 4;17(2):484-500
pubmed: 27705796
N Engl J Med. 2003 Jun 19;348(25):2543-56
pubmed: 12815141
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):703-9
pubmed: 25649157
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5726-5734
pubmed: 30513533
Kidney Int Rep. 2018 Aug 22;3(6):1239-1241
pubmed: 30450445
JAMA Ophthalmol. 2013 Jun;131(6):777-82
pubmed: 23572034
Br Med J. 1927 Mar 19;1(3454):504-6
pubmed: 20773074
Development. 2004 Apr;131(7):1619-28
pubmed: 14998921
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1621-7
pubmed: 19850830
Br J Ophthalmol. 2017 Jul;101(7):985-988
pubmed: 27899366
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3907-13
pubmed: 27472076
Clin Exp Nephrol. 2019 Feb;23(2):158-168
pubmed: 30128941
Ophthalmology. 1984 Jun;91(6):603-12
pubmed: 6462623
Am J Ophthalmol. 2012 Nov;154(5):767-778.e2
pubmed: 22935600
Retin Cases Brief Rep. 2014 Winter;8(1):52-5
pubmed: 25372209
PLoS One. 2018 Oct 18;13(10):e0205773
pubmed: 30335815
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1713-1720
pubmed: 27287265
J Biol Chem. 2002 Aug 23;277(34):31154-62
pubmed: 12039968

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH